Fundraising Fox

Alnylam

3 known investors

alnylam.com ↗

Alnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.

BiotechDigital HealthMedical Devices

Investors · 3

ARCH Venture PartnersChicago
Atlas VentureCambridge
Cardinal PartnersPrinceton

In the news